American Clinical Laboratory Association lauds ADA’s recommendation of HbA1C test for diabetes Convenience of non-fasting diabetes test could encourage assessment The American Clinical Laboratory Association’s Results for Life Campaign today applauded the American Diabetes Association because of its decision to recommend the hemoglobin A1C laboratory test as a means of diagnosing diabetes and identifying pre-diabetes. The new ADA clinical practice suggestion was released as a health supplement to the January issue of Diabetes Care site . Related StoriesDiabetes prevention begins in the wombNew Cleveland Clinic research shows bariatric surgery is safe choice for managing type 2 diabetes in overweight or mildly obese patientsBariatric operation improves weight, metabolic health and quality of life in adolescents after 3 years This recommendation can help in the battle against diabetes because the HbA1C test, unlike other tests, does not require individuals to fast ahead of time, said David Mongillo, Vice President of Plan and Medical Affairs for the American Clinical Laboratory Association.

Amenorrhea Diagnosis A doctor may perform the next tests to determine the reason behind the amenorrhea: Blood tests may be performed to determine the levels of hormones secreted by the pituitary gland and the ovaries . Ultrasonography of the pelvis could be performed to measure the abnormalities of the genital system or to search for polycystic ovaries. CT scan or MRI of the head could be performed to exclude pituitary and hypothalamic causes of amenorrhea. If the above checks are inconclusive, additional lab tests could be performed including: Thyroid function tests Determination of prolactin levels Hysterosalpingogram or saline infusion sonography , both of which examine the uterus Hysteroscopy ..